LATTANZI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 3.491
AS - Asia 1.745
EU - Europa 1.176
Continente sconosciuto - Info sul continente non disponibili 275
SA - Sud America 202
AF - Africa 178
OC - Oceania 3
Totale 7.070
Nazione #
US - Stati Uniti d'America 3.407
SG - Singapore 606
IT - Italia 503
CN - Cina 353
VN - Vietnam 249
HK - Hong Kong 209
DE - Germania 205
BR - Brasile 155
IN - India 146
FI - Finlandia 108
SE - Svezia 81
RU - Federazione Russa 51
FR - Francia 50
ZA - Sudafrica 49
BJ - Benin 43
CA - Canada 43
BD - Bangladesh 36
BG - Bulgaria 31
TG - Togo 28
GB - Regno Unito 27
JP - Giappone 25
ID - Indonesia 24
IE - Irlanda 22
AR - Argentina 21
BZ - Belize 19
CI - Costa d'Avorio 19
IQ - Iraq 18
NL - Olanda 16
MA - Marocco 15
UA - Ucraina 12
PL - Polonia 11
TR - Turchia 11
AT - Austria 9
PK - Pakistan 9
AE - Emirati Arabi Uniti 8
KE - Kenya 8
ES - Italia 7
MY - Malesia 7
RO - Romania 7
VE - Venezuela 7
BE - Belgio 6
PH - Filippine 6
TH - Thailandia 6
CL - Cile 5
KR - Corea 5
MX - Messico 5
PE - Perù 5
AL - Albania 4
EC - Ecuador 4
EE - Estonia 4
JO - Giordania 4
LT - Lituania 4
PT - Portogallo 4
SA - Arabia Saudita 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EG - Egitto 3
IR - Iran 3
JM - Giamaica 3
NI - Nicaragua 3
RS - Serbia 3
TN - Tunisia 3
AZ - Azerbaigian 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
KZ - Kazakistan 2
PA - Panama 2
PS - Palestinian Territory 2
PY - Paraguay 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
UZ - Uzbekistan 2
AO - Angola 1
AU - Australia 1
BS - Bahamas 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
EU - Europa 1
IL - Israele 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
NR - Nauru 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
SN - Senegal 1
TJ - Tagikistan 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.797
Città #
Ashburn 466
Fairfield 402
Singapore 369
San Jose 267
Hong Kong 201
Woodbridge 187
Chandler 147
Seattle 143
Houston 137
Cambridge 131
Rome 127
Wilmington 115
Dallas 92
Ann Arbor 89
Frankfurt am Main 82
Beijing 76
Council Bluffs 75
Los Angeles 72
Ho Chi Minh City 69
Helsinki 67
Milan 66
Santa Clara 63
Hanoi 57
San Paolo di Civitate 56
Hefei 54
Princeton 52
Dearborn 51
Johannesburg 41
Fasano 38
Munich 37
Lawrence 34
Buffalo 33
Plano 33
Sofia 31
Lauterbourg 29
New York 29
San Diego 29
Hillsboro 28
Lomé 28
Millbury 25
Cosenza 24
Turku 24
Boston 22
Bremen 22
Tokyo 22
Chicago 21
Fremont 20
Phoenix 20
São Paulo 20
Abidjan 19
Belize City 19
Moscow 19
Redondo Beach 18
Atlanta 17
Da Nang 17
Jakarta 17
Andover 16
Figino 16
Haiphong 16
The Dalles 16
Dublin 13
Shanghai 13
Toronto 13
Falkenstein 12
Shenyang 12
Baghdad 11
Nuremberg 10
Ottawa 10
Saint Louis 10
Warsaw 10
Miano 9
Casablanca 8
Columbus 8
Nairobi 8
Boardman 7
Mannheim 7
Bengaluru 6
Biên Hòa 6
Brussels 6
Chengdu 6
Huskvarna 6
Monza 6
Mumbai 6
Nanjing 6
Norwalk 6
Rio de Janeiro 6
Schiffdorf 6
Washington 6
Amsterdam 5
Belo Horizonte 5
Bologna 5
Bắc Ninh 5
Can Tho 5
Falls Church 5
Florence 5
Guangzhou 5
Hyderabad 5
Islamabad 5
Jena 5
Montreal 5
Totale 4.806
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 237
Sarcopenic obesity in fatty liver 234
Muscle alterations are associated with minimal and overt hepatic encephalopathy in patients with liver cirrhosis 230
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 224
Donor-to-recipient gender match in liver transplantation. A systematic review and meta-analysis 217
A low muscle mass increases mortality in compensated cirrhotic patients with sepsis 206
Donor liver small droplet macrovesicular steatosis is associated with reduced graft survival after liver transplantation 205
Donor small-droplet macrovesicular steatosis affects liver transplant outcome in HCV-negative recipients 205
Prevalence and impact of sarcopenia in non-cirrhotic portal hypertension 197
Acute rejection on immune-mediated chronic rejection after liver transplantation 192
The multidisciplinary support in preventing alcohol relapse after liver transplantation: a single centre experience 188
Microbial translocation and T cell activation are modified by direct-acting antiviral therapy in HCV-infected patients 186
Is the multidisciplinary support effective in preventing alcohol relapse after liver transplantation? 177
Hepatic Encephalopathy Expands the Predictivity of Meld in Liver Transplant Setting: Evidence by Means of two Independent Cohorts 167
Conversion from twice-daily to once-daily Tacrolimus administration in liver transplant patient: results of long term follow-up. 162
The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease 162
MELDNa score is associated with psychopathology and reduced quality of life in cirrhotic patients with a liver transplant perspective 161
The impact of multidisciplinary support to alcohol misusers at risk of alcohol relapse after liver transplantation 156
Ischemic Damage Represents the Main Risk Factor for Biliary Stricture After Liver Transplantation: A Follow-Up Study in a Danish Population 155
Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt 155
Albumin infusion in cirrhotic patients with infections other than spontaneous bacterial peritonitis: End of the story? 154
The effect of 12 weeks of β-hydroxy-β-methyl-butyrate supplementation after liver transplantation. A pilot randomized controlled study 154
May sarcopenia and/or hepatic encephalopathy improve the predictivity of model for end-stage liver disease? 148
Predictive factors for the eradication of esophageal varices in cirrhotic patient undergoing endoscopic band ligation 147
The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey 146
Increased risk of cognitive impairment in cirrhotic patients with bacterial infections 144
Changes in nutritional status after liver transplantation. 140
Hepatic Encephalopathy and Sarcopenia: Two Faces of the Same Metabolic Alteration 138
Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey 137
Weight gain and de novo metabolic disorders after liver transplantation 135
Comunicazionepuntodoc (2015). Vol. 13: Media & terror 134
HIGH PREVALENCE OF MDR INFECTIONS IN CIRRHOTIC PATIENTS WHO HAVE HAD CONTACT WITH THE HEALTHCARE SYSTEM 134
Beta-blockers in liver cirrhosis. 131
Graft macrosteatosis and time of T-tube removal as risk factors for biliary strictures after liver transplantation 127
The effects of 12-week beta-hydroxy-beta-methylbutyrate supplementation in patients with liver cirrhosis: results from a randomized controlled single-blind pilot study 125
Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: Results of a prospective study 124
Nutritional assessment and management for hospitalized patients with cirrhosis 123
The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS 121
Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy x-ray absorptiometry and anthropometry 120
Cumulative incidence of solid and hematological De novo malignancy after liver transplantation in a multicentre cohort 115
Efficacy of albumin treatment for patients with cirrhosis and infections unrelated to spontaneous bacterial peritonitis 114
Nutritional therapy in the management of physical frailty and sarcopenia 113
Liver transplantation for severe alcoholic hepatitis: a multicenter Italian study 110
The use of non-selective beta-blockers in patients with cirrhosis: more doubts than certainties 80
null 70
null 40
Integrating Advanced Endoscopic Techniques and Confocal Microscopy for Early Detection of Extrahepatic Cholangiocarcinoma 22
Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement 8
Totale 7.070
Categoria #
all - tutte 18.921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.921


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022468 0 0 45 26 70 11 10 51 73 33 76 73
2022/2023627 96 162 49 98 55 46 5 41 44 8 20 3
2023/2024333 31 37 14 22 33 60 9 23 3 36 36 29
2024/20251.003 17 51 81 53 54 50 67 57 139 84 84 266
2025/20262.434 227 61 211 210 307 132 414 104 189 333 142 104
2026/2027278 58 188 32 0 0 0 0 0 0 0 0 0
Totale 7.070